Launched in 2017, OFF-X has now reached 500,000 curated safety alerts corresponding to almost 15,000 targets of pharmacological interest and almost 14,500 drugs and biologics.
More info
Bioinfogate is pleased to announce successful completion of the R&D innovation project "DEVELOPMENT OF AN ARTIFICIAL INTELLIGENCE PLATFORM TO ANTICIPATE AND MINIMIZE THE RISKS ASSOCIATED WITH THE SAFETY OF DRUGS FROM THEIR PHASE OF DISCOVERY THROUGH THEIR USE IN CLINICAL PRACTICE".
More info
Bioinfogate has been invited to a speak at the Chem-Bio Informatics Society (CBI) Annual Meeting ""Towards Seamless Integration of Structural Biology and Information Science"~Dawn of the AI era in drug discovery~" which takes place in Tokyo, Oct. 22-24, 2019.
More info

Our advanced data analytics solutions address the challenges of molecular and biological complexity in drug discovery.

We connect emerging data sources and life science content into advanced knowledge management platforms that deliver meaningful biomedical intelligence.

Learn more about our solutions